Top 10 Ramipril (Altace) Generic Manufacturers in Brazil

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The pharmaceutical industry in Brazil has been experiencing significant growth in recent years, with a focus on the production and distribution of generic medications. Ramipril, also known by the brand name Altace, is a commonly prescribed medication for high blood pressure and heart failure. In this report, we will explore the top 10 Ramipril generic manufacturers in Brazil, highlighting key players in the market and their contributions to the industry.

Top 10 Ramipril (Altace) Generic Manufacturers in Brazil:

1. EMS Pharma
EMS Pharma is one of the leading generic pharmaceutical companies in Brazil, with a strong presence in the market for Ramipril generics. The company has a production volume of over 1 million units per year, making it a key player in the industry.

2. Eurofarma
Eurofarma is another major player in the Brazilian pharmaceutical market, producing a significant amount of Ramipril generics each year. With a market share of over 20%, Eurofarma is a key competitor in the industry.

3. Teuto
Teuto is known for its high-quality generic medications, including Ramipril generics. The company has a strong export market, with a trade value of over $5 million in Ramipril generics.

4. Aché
Aché is a well-established pharmaceutical company in Brazil, producing a substantial amount of Ramipril generics each year. The company’s focus on research and development has helped it maintain a competitive edge in the market.

5. Germed
Germed is a key player in the Brazilian pharmaceutical industry, with a significant market share in Ramipril generics. The company’s commitment to quality and innovation has helped it become a top manufacturer in the market.

6. Biolab
Biolab is a leading pharmaceutical company in Brazil, known for its wide range of generic medications, including Ramipril generics. The company’s strong distribution network has helped it reach a wide customer base in the country.

7. EMS Sigma Pharma
EMS Sigma Pharma is a subsidiary of EMS Pharma, specializing in the production of generic medications, including Ramipril generics. The company’s focus on innovation and efficiency has helped it gain a competitive advantage in the market.

8. Cristália
Cristália is a key player in the Brazilian pharmaceutical industry, producing a significant amount of Ramipril generics each year. The company’s commitment to research and development has helped it expand its market reach.

9. Prati-Donaduzzi
Prati-Donaduzzi is a major pharmaceutical company in Brazil, known for its high-quality generic medications, including Ramipril generics. The company’s strong export market has helped it establish a global presence in the industry.

10. EMS Genéricos
EMS Genéricos is a subsidiary of EMS Pharma, specializing in the production of generic medications, including Ramipril generics. The company’s focus on affordability and accessibility has helped it gain a competitive edge in the market.

Insights:

The market for Ramipril generics in Brazil is expected to continue growing in the coming years, driven by an increasing demand for affordable medications. With a focus on innovation and quality, top manufacturers like EMS Pharma, Eurofarma, and Teuto are poised to maintain their dominance in the industry. As the pharmaceutical industry in Brazil continues to evolve, companies that prioritize research and development will be best positioned to succeed in the competitive market.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →